In the realm of peptide research, MOTS-c and ADM5 are two compounds that have been studied for their roles in metabolic regulation. MOTS-c, a mitochondrial-derived peptide with exercise-mimetic properties, and ADM5, also known as Adropin, are both implicated in energy metabolism and glucose homeostasis. This comparison aims to provide an overview of their respective classes, mechanisms, and potential applications based on the available scientific literature.
| MOTS-c (mitochondrial-derived peptide, exercise-mimetic) | ADM5 (Adropin/Adropin-related metabolic peptide) | |
|---|---|---|
| Drug class | MOTS-c is a mitochondrial-derived peptide with exercise-mimetic effects. | ADM5 is a peptide hormone involved in energy metabolism and glucose homeostasis. |
| Mechanism | MOTS-c activates AMPK and PGC1α, leading to improved glucose metabolism and enhanced mitochondrial biogenesis. | The mechanism of ADM5 is not detailed in the provided source material. |
| Primary use | MOTS-c has potential benefits for type 2 diabetes and insulin resistance, as well as weight management and metabolic health. | ADM5 is implicated in the pathophysiology of obesity, type 2 diabetes, and other metabolic disorders. |
| Administration | Typical injectable protocol for MOTS-c is not well-established due to its experimental nature. | Typical injectable protocol for ADM5 is not detailed in the provided source material. |
| Evidence strength | MOTS-c's benefits are supported by preclinical models showing improved insulin sensitivity and glucose tolerance. | ADM5's role in metabolic regulation is supported by its implication in the pathophysiology of metabolic disorders. |
| Safety and side effects | Safety profile and potential side effects of MOTS-c are not fully established. | Safety profile and potential side effects of ADM5 are not detailed in the provided source material. |
Mechanism of Action
MOTS-c is a mitochondrial-derived peptide that exhibits exercise-mimetic effects by activating AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1α) [37]. This activation leads to improved glucose metabolism, increased fatty acid oxidation, and enhanced mitochondrial biogenesis. In contrast, the mechanism of ADM5 is not detailed in the provided source material, although it is known to be a peptide hormone involved in the regulation of energy metabolism and glucose homeostasis [48].
Primary Use and Benefits
MOTS-c has shown potential benefits in preclinical models for individuals with type 2 diabetes or insulin resistance by improving insulin sensitivity and glucose tolerance [37]. It may also have applications in weight management and promoting a more oxidative metabolic phenotype. ADM5, on the other hand, is implicated in the pathophysiology of obesity, type 2 diabetes, and other metabolic disorders [48], suggesting its potential role in metabolic regulation.
Administration and Safety
The typical injectable protocol for MOTS-c is not well-established due to its experimental nature, and the safety profile and potential side effects are not fully established [37]. Similarly, the typical injectable protocol and safety profile for ADM5 are not detailed in the provided source material. It is important to note that further research is needed to establish the safety and efficacy of both peptides.
Evidence Strength
The evidence supporting the benefits of MOTS-c comes from preclinical models that demonstrate improved insulin sensitivity and glucose tolerance [37]. For ADM5, its role in metabolic regulation is supported by its implication in the pathophysiology of metabolic disorders [48]. Both peptides require further clinical research to confirm their therapeutic potential and safety.
References
- Cosmetic Dermatology_ Products and Procedures
- Endocrinology_ Adult and Pediatric
- GPCRs_ From Deorphanization to Lead Structure Identification
- Handbook of Biologically Active Peptides
- Hypothalamic Integration of Energy Metabolism
- Kosmetik für Ärzte und Apotheker
- Life Force
- Living a Fully Optimized Life
- Mechanisms of Photoaging and Cutaneous Photocarcinogenesis
- Peptide Protocols Volume One — William A Seeds MD
- Peptide Therapeutics_ Design and Development
- Peptide and Protein Design for Biopharmaceutical Applications
- Peptides_ Chemistry and Biology, 2nd Edition
- Pharmacology
- Photoimmunology of Langerhans cells
- The Perricone Prescription
- The Pineal and its Hormones
- Therapeutic Peptides and Proteins Formulation, Processing — Ajay K Banga
- Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
- α-MSH related peptides_ a new class of anti-inflammatory and immunomodulating drugs